Quaker Chemical VP granted 297 RSUs

Meagher Kevin K. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Meagher Kevin K. reported acquisition or exercise transactions in this Form 4 filing.

Quaker Chemical Corporation executive Kevin K. Meagher, VP, R&D - Advanced Solutions, received a grant of 297 Restricted Stock Units (RSUs) as equity-based compensation. Each RSU represents a contingent right to receive one share of KWR common stock, with dividend equivalent rights accruing as dividends are paid.

The time-based RSUs will vest in three annual installments beginning on March 15, 2027, aligning Mr. Meagher’s long-term incentives with shareholders. Following this grant, he holds 297 RSUs directly, all subject to future vesting conditions.

Insider Trade Summary

Grant/Award: 297 shares

Grant/Award 1 txn

Insider Meagher Kevin K.

Role VP, R&D - Advanced Solutions

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	297	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 297 contracts (Direct)

Footnotes (1)

1. F1. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Quaker Chemical (KWR) disclose about Kevin Meagher in this Form 4?

Quaker Chemical reported that Kevin K. Meagher, VP, R&D - Advanced Solutions, received a grant of 297 Restricted Stock Units. These units are compensation-based awards that can convert into shares of KWR common stock if future vesting conditions are met over time.

How many Restricted Stock Units were granted to Kevin Meagher at Quaker Chemical (KWR)?

Kevin K. Meagher was granted 297 Restricted Stock Units. Each RSU represents a contingent right to receive one share of KWR common stock, giving him potential future ownership tied to meeting the specified time-based vesting schedule under the company’s incentive plan.

When do Kevin Meagher’s Quaker Chemical (KWR) RSUs begin vesting?

The time-based Restricted Stock Units granted to Kevin K. Meagher will begin vesting on March 15, 2027. Vesting occurs in three annual installments from that date, meaning the award converts into common shares gradually rather than all at once, supporting long-term retention.

What does each Restricted Stock Unit represent in the Quaker Chemical (KWR) grant?

Each RSU granted to Kevin K. Meagher represents a contingent right to receive one share of Quaker Chemical common stock. The units only convert into actual shares as they vest over time, subject to the conditions of the company’s Long-Term Performance Incentive Plan.

Do Kevin Meagher’s Quaker Chemical (KWR) RSUs include dividend-related rights?

Yes. Dividend equivalent rights, or DERs, accrue on these RSUs when and as dividends are paid on Quaker Chemical common stock. This means the award is designed to mirror the economic benefit of dividends during the vesting period, enhancing the long-term incentive value.

How many Quaker Chemical (KWR) RSUs does Kevin Meagher hold after this grant?

After this grant, Kevin K. Meagher holds 297 Restricted Stock Units directly. These units are derivative interests rather than currently outstanding shares, and they will convert into KWR common stock only as they satisfy the specified time-based vesting conditions starting in 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meagher Kevin K.

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PA 19428-2380

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, R&D - Advanced Solutions

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/15/2026		A		297		(1)	(1)	Common Stock	297	$0	297	D

Explanation of Responses:

1. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Kevin K. Meagher	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.